| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 78.337 | 94.257 | 100.508 |
| Total Income - EUR | - | - | - | - | - | 0 | 26 | 78.354 | 94.259 | 100.510 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 4.984 | 39.319 | 67.215 | 73.112 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 0 | -4.958 | 39.035 | 27.044 | 27.398 |
| Net Profit/Loss - EUR | - | - | - | - | - | 0 | -4.959 | 38.267 | 26.148 | 24.836 |
| Employees | - | - | - | - | - | 0 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Dr. Adina Camelia Sirbu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 42.586 | 38.538 | 28.267 | 19.395 |
| Current Assets | - | - | - | - | - | 41 | 6.084 | 12.704 | 27.752 | 33.753 |
| Inventories | - | - | - | - | - | 0 | 246 | 608 | 2.872 | 3.514 |
| Receivables | - | - | - | - | - | 0 | 5.054 | 6.051 | 19.323 | 7.778 |
| Cash | - | - | - | - | - | 41 | 785 | 6.045 | 5.558 | 22.461 |
| Shareholders Funds | - | - | - | - | - | 41 | -4.918 | 33.334 | 21.238 | 16.329 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 0 | 53.588 | 17.907 | 34.782 | 36.819 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Adina Camelia Sirbu S.r.l.